Episode 8. Management of Newly Diagnosed CLL
Blood Cancer Talks
00:00
The Evolution of Chemotherapy
Microglobulin has some relevance in terms of prognostication, we do check it as a standard for our patients who come in. But again whether that's going to affect my treatment decision, not really. So I think those have somewhat lost prognostic significance in the new era I would say. Now moving on to treatment, once you have the complete work of including cytogenetics and mutation status available. Can you walk us through your thought process and how you pick the optimal treatment regimen by a previously untreated patient? You know this is a very obviously important right how to pick the new treatment.
Transcript
Play full episode
